Miroslav Blumenberg

New York University Langone Medical Center

Miroslav Blumenberg, PhD, was born in Subotica and received his BSc in Belgrade, Yugoslavia. He completed his PhD at MIT in Organic Chemistry; he followed up his PhD with two postdoctoral study periods at Stanford University. Since 1983, he has been a faculty member of the RO Perelman Department of Dermatology, NYU School of Medicine, where he is a codirector of a training grant in cutaneous biology. Dr. Blumenberg’s research is focused on the epidermis, expression of keratin genes, transcription profiling, keratinocyte differentiation, inflammatory diseases and cancers, and most recently the effects of the microbiome on skin. He has published more than 100 peer-reviewed research articles and graduated numerous PhD and postdoctoral students. Dr. Blumenberg lives in New York, USA, with his wife and two children.

6books edited

5chapters authored

Latest work with IntechOpen by Miroslav Blumenberg

The recent breakthrough in microbial studies has applied next-generation sequencing (NGS), a massive omics analysis, to the composition and structure of microbial communities. NGS can identify microbes without the need for their cultivation. Their mere presence can be ascertained and often quantitated, and even their metabolic capabilities of microbial constituents predicted. This breakthrough led to an explosive growth in research on microbes. Many important advances have been made in human health-related studies. Indeed, gut microbial communities have been extensively analyzed and differences between healthy and diseased microbiomes have been determined. Studies of the effects of changes of diet, of antibiotic treatments, and of probiotics have been published. Specific attention has been devoted to human pathogens, their mechanisms of causing disease, and the potentials for their management and treatment. Microbiome studies of natural habitats, terrestrial and aquatic, have also benefited from NGS methodology. Increased understanding of the microbial communities has led to the use microbes as antagonists of pathogens, i.e. as treatments. Moreover, novel uses of microbes in industrial processes, either for synthesis of important compounds or for degradation and handling of waste, are being devised. In this volume, chapters dealing with the cutting-edge research in all these fields are presented.

Go to the book